Published in Hum Reprod on March 01, 2000
Diagnostic reproducibility of hydatidiform moles: ancillary techniques (p57 immunohistochemistry and molecular genotyping) improve morphologic diagnosis. Am J Surg Pathol (2012) 0.89
Molecular genetic analysis of placental site trophoblastic tumors and epithelioid trophoblastic tumors confirms their trophoblastic origin. Am J Pathol (2002) 0.89
Discovery of a cell: reflections on the checkered history of intermediate trophoblast and update on its nature and pathologic manifestations. Int J Gynecol Pathol (2014) 0.75
STR DNA genotyping of hydatidiform moles in South China. Int J Clin Exp Pathol (2014) 0.75
Partial molar pregnancy after intracytoplasmic sperm injection occurring as a result of diploid sperm usage. J Assist Reprod Genet (2013) 0.75
Molecular and Immunohistochemical Characteristics of Complete Hydatidiform Moles. Balkan J Med Genet (2017) 0.75
Results from the first year of the New Zealand cot death study. N Z Med J (1991) 5.02
Which doctors die first? Analysis of BMJ obituary columns. BMJ (1997) 2.99
Evaluation of a technique for the estimation of serum bactericidal activity against Gram-negative organisms. Med Lab Technol (1972) 2.19
Temozolomide: a new oral cytotoxic chemotherapeutic agent with promising activity against primary brain tumours. Eur J Cancer (1993) 2.18
Choriocarcinoma and partial hydatidiform moles. Lancet (2000) 2.15
Micrococcaceae from the uinary tract in pregnancy. J Clin Pathol (1967) 2.14
Prevention of urinary-tract infection with low-dose nitrofurantoin. Lancet (1971) 2.13
Serum resistance among Escherichia coli strains causing urinary tract infection in relation to O type and the carriage of hemolysin, colicin, and antibiotic resistance determinants. Infect Immun (1982) 2.12
Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000. J Clin Oncol (2002) 2.06
EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients. J Clin Oncol (1997) 2.00
Comparison of ondansetron and ondansetron plus dexamethasone as antiemetic prophylaxis during cisplatin-containing chemotherapy. Lancet (1991) 1.95
Further advances in the management of malignant teratomas of the testis and other sites. Lancet (1983) 1.80
Histopathology in the prediction of relapse of patients with stage I testicular teratoma treated by orchidectomy alone. Lancet (1987) 1.79
Phase I trial of temozolomide using an extended continuous oral schedule. Cancer Res (1998) 1.70
Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma. Cancer Chemother Pharmacol (1997) 1.68
The Second Medical Research Council study of prognostic factors in nonseminomatous germ cell tumors. Medical Research Council Testicular Tumour Working Party. J Clin Oncol (1992) 1.67
Surveillance for stage I testicular germ cell tumours: results and cost benefit analysis of management options. Eur J Cancer (2000) 1.66
Rapid coupling between ice volume and polar temperature over the past 150,000 years. Nature (2012) 1.61
Cancer Research Campaign phase II trial of temozolomide in metastatic melanoma. J Clin Oncol (1995) 1.61
Depletion of O6-alkylguanine-DNA alkyltransferase correlates with potentiation of temozolomide and CCNU toxicity in human tumour cells. Br J Cancer (1993) 1.60
Lifetime suicide rates in treated schizophrenia: 1875-1924 and 1994-1998 cohorts compared. Br J Psychiatry (2006) 1.58
High serum vitamin B12 binding capacity as a marker of the fibrolamellar variant of hepatocellular carcinoma. Br Med J (Clin Res Ed) (1982) 1.55
Combination but not single-agent methotrexate chemotherapy for gestational trophoblastic tumors increases the incidence of second tumors. J Clin Oncol (1996) 1.54
Carboplatin or cisplatin? Lancet (1988) 1.53
Developments in chemotherapy for medium- and high-risk patients with gestational trophoblastic tumours (1979-1984). Br J Obstet Gynaecol (1986) 1.53
Further evidence supporting a causal relationship between prone sleeping position and SIDS. J Paediatr Child Health (1992) 1.49
Phase I clinical trial of mitozolomide. Cancer Treat Rep (1985) 1.48
Chemotherapy for ovarian germ cell tumours. Eur J Cancer (1996) 1.48
Current optimum management of anaplastic germ cell tumours of the testis and other sites. Br J Urol (1986) 1.48
Rapid diagnosis and classification of hydatidiform moles with polymerase chain reaction. Am J Obstet Gynecol (1993) 1.45
Serum bactericidal activity in patients with upper and lower urinary tract infections. Clin Sci (1972) 1.42
POMB/ACE chemotherapy for mediastinal germ cell tumours. Eur J Cancer (1997) 1.40
Reducing incidence of headache after lumbar puncture and intrathecal cytotoxics. Lancet (1999) 1.40
Chemotherapy of advanced malignant teratomas. Br J Cancer (1980) 1.40
Problems of interpretation of serum concentrations of alpha-foetoprotein (AFP) in patients receiving cytotoxic chemotherapy for malignant germ cell tumours. Br J Cancer (1983) 1.40
Single-dose therapy of anogenital and pharyngeal gonorrhoea with ciprofloxacin. Int J STD AIDS (1992) 1.38
Some factors affecting bacterial colony counts in urinary infection. Br Med J (1967) 1.38
Single agent activity of carboplatin in patients with previously untreated non-seminomatous germ cell tumours. Ann Oncol (1992) 1.38
3-aminobenzamide and/or O6-benzylguanine evaluated as an adjuvant to temozolomide or BCNU treatment in cell lines of variable mismatch repair status and O6-alkylguanine-DNA alkyltransferase activity. Br J Cancer (1996) 1.38
The use of significant others as proxy raters of the quality of life of patients with brain cancer. Med Care (1997) 1.37
Distribution of the Ca (Oxford) antigen in lung neoplasms and non-neoplastic lung tissues. J Clin Pathol (1984) 1.35
The role of low-dose methotrexate and folinic acid in gestational trophoblastic tumours (GTT). Br J Obstet Gynaecol (1989) 1.35
Risk of recurrent hydatidiform mole and subsequent pregnancy outcome following complete or partial hydatidiform molar pregnancy. BJOG (2003) 1.32
In vitro evaluation of temozolomide combined with X-irradiation. Anticancer Drugs (1997) 1.32
Tissue distribution and tumour localization of 99m-technetium-labelled liposomes in cancer patients. Br J Cancer (1979) 1.32
Presentation and management of choriocarcinoma after nonmolar pregnancy. Br J Obstet Gynaecol (1995) 1.31
Central nervous system metastases of choriocarcinoma. 23 years' experience at Charing Cross Hospital. Cancer (1983) 1.31
O6-methylguanine-DNA methyltransferase in pretreatment tumour biopsies as a predictor of response to temozolomide in melanoma. Br J Cancer (1998) 1.29
Characterization of the ends and target sites of the novel conjugative transposon Tn5397 from Clostridium difficile: excision and circularization is mediated by the large resolvase, TndX. J Bacteriol (2000) 1.27
Hyperplasia and prolapse of hepatocytes into hepatic veins during longterm methyltestosterone therapy: possible relationships of these changes to the developement of peliosis hepatis and liver tumours. Histopathology (1977) 1.25
Liver damage from long-term methyltestosterone. Lancet (1977) 1.25
Natural history of liver disease in chronic hepatitis B surface antigen carriers. Survey of 100 patients from Great Britain. Lancet (1981) 1.24
Posterior reversible encephalopathy syndrome: a possible late interaction between cytotoxic agents and general anaesthesia. Neuroradiology (2005) 1.22
Urinary and faecal Escherichia coli O-sero-groups in symptomatic urinary-tract infection and asymptomatic bacteriuria. J Med Microbiol (1975) 1.22
Pseudo-partial moles: placental stem vessel hydrops and the association with Beckwith-Wiedemann syndrome and complete moles. Histopathology (2001) 1.20
A case of metastatic transitional cell carcinoma in the testis histologically mimicking intratubular germ cell neoplasia. Br J Urol (1996) 1.18
The rise and fall of Escherichia coli O15 in a London teaching hospital. J Med Microbiol (1990) 1.17
Distribution of some newer antibiotics within the kidney interstitium: a therapeutic consideration in pyelonephritis. Invest Urol (1967) 1.17
Treatment of men with metastatic non-seminomatous germ cell tumours with cyclical POMB/ACE chemotherapy. Ann Oncol (1997) 1.16
What sort of oncology team should treat testicular teratoma? Lancet (1985) 1.16
Cholangiocarcinoma coexisting with developmental liver cysts: a distinct entity different from liver cystadenocarcinoma. Histopathology (1980) 1.15
Weekly alternating etoposide, methotrexate, and actinomycin/vincristine and cyclophosphamide chemotherapy for the treatment of CNS metastases of choriocarcinoma. J Clin Oncol (1989) 1.14
From triazines and triazenes to temozolomide. Eur J Cancer (1993) 1.14
Bacteria causing symptomatic urinary tract infection or asymptomatic bacteriuria. J Clin Pathol (1979) 1.14
VP16-213 as a single agent in advanced testicular tumors. Eur J Cancer (1980) 1.13
Ondansetron (GR38032F) plus dexamethasone: effective anti-emetic prophylaxis for patients receiving cytotoxic chemotherapy. Br J Cancer (1990) 1.10
Manpower and workload in adult renal medicine in the United Kingdom 1975-82. Br Med J (Clin Res Ed) (1984) 1.09
Diagnosis of urinary-tract infection in general practice. Lancet (1972) 1.09
Effect of subinhibitory concentrations of four commonly used biocides on the conjugative transfer of Tn916 in Bacillus subtilis. J Antimicrob Chemother (2013) 1.09
Gestational trophoblastic tumours following initial diagnosis of partial hydatidiform mole. Lancet (1990) 1.08
Orbitally induced oscillations in the East Antarctic ice sheet at the Oligocene/Miocene boundary. Nature (2001) 1.08
Potentiation of temozolomide and BCNU cytotoxicity by O(6)-benzylguanine: a comparative study in vitro. Br J Cancer (1996) 1.08
Assessment of suicide risk by computer-delivered self-rating questionnaire: preliminary findings. Acta Psychiatr Scand (1989) 1.07
Urinary-tract infection in non-pregnant women. Lancet (1973) 1.07
Utility of commonly used commercial human chorionic gonadotropin immunoassays in the diagnosis and management of trophoblastic diseases. Clin Chem (2001) 1.07
Clinical trial of combination chemotherapy and specific active immunotherapy in disseminated melanoma. Br J Cancer (1976) 1.06
Epipodophylin derivative (VP 16-23) in malignant teratomas and choriocarcinomas. Lancet (1977) 1.06
Effect of single and multiple administration of an O6-benzylguanine/temozolomide combination: an evaluation in a human melanoma xenograft model. Cancer Chemother Pharmacol (1997) 1.06
Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumours. Br J Cancer (1999) 1.06
O6-benzylguanine enhances the sensitivity of a glioma xenograft with low O6-alkylguanine-DNA alkyltransferase activity to temozolomide and BCNU. Br J Cancer (1996) 1.05
Safety of surveillance in the management of stage I anaplastic germ cell tumours of the testis. Br J Urol (1988) 1.05
Salvage chemotherapy of relapsed or high-risk gestational trophoblastic neoplasia (GTN) with paclitaxel/cisplatin alternating with paclitaxel/etoposide (TP/TE). Ann Oncol (2008) 1.04
Histological features of skin reactions to human lymphoid cell line lymphokine in patients with advanced cancer. J Pathol (1982) 1.03
Postchemotherapy residual masses in germ cell tumor patients: content, clinical features, and prognosis. Medical Research Council Testicular Tumour Working Party. Cancer (1998) 1.02
Long-term outcome in patients with germ cell tumours treated with POMB/ACE chemotherapy: comparison of commonly used classification systems of good and poor prognosis. Br J Cancer (1989) 1.01
Response of differentiated but not anaplastic teratoma to interferon. Br J Cancer (1984) 1.00
Early warning skin signs in AIDS and persistent generalized lymphadenopathy. Br J Dermatol (1986) 0.99
DNA sequence of the insertional hot spot of Tn916 in the Clostridium difficile genome and discovery of a Tn916-like element in an environmental isolate integrated in the same hot spot. FEMS Microbiol Lett (2000) 0.99
Plasma and tissue disposition of mitozolomide in mice. Br J Cancer (1986) 0.99
Placental site trophoblastic tumour (trophoblastic pseudotumour): a study of four cases requiring hysterectomy including one fatal case. Histopathology (1982) 0.99
Central core disease: clinical, pathological, and genetic features. Arch Dis Child (2003) 0.98
Prophylaxis against hypomagnesaemia induced by cis-platinum combination chemotherapy. Cancer Chemother Pharmacol (1982) 0.97
Paclitaxel-containing high-dose chemotherapy for relapsed or refractory testicular germ cell tumours. Br J Cancer (2004) 0.97
Surveillance policy for stage I ovarian germ cell tumors. J Clin Oncol (1997) 0.96
Mechanism of integration and excision in conjugative transposons. Cell Mol Life Sci (2002) 0.95
Diversity of putative Tn5253-like elements in Streptococcus pneumoniae. Int J Antimicrob Agents (2008) 0.95
Bone disease in testicular and extragonadal germ cell tumours. Br J Cancer (1988) 0.95
Qualitative assessment of midstream urine cultures in the detection of bacteriuria. Clin Nephrol (1975) 0.95